Literature DB >> 19625969

Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.

Martin Ritt1, Joanna M Harazny, Christian Ott, Markus P Schneider, Markus P Schlaich, Georg Michelson, Roland E Schmieder.   

Abstract

OBJECTIVE: We hypothesized that wall-to-lumen ratio (WLR) of retinal arterioles might serve as an in-vivo parameter of vascular damage. To test this hypothesis we examined whether WLR of retinal arterioles is related with increased urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine (L-NMMA).
METHODS: Thirty-nine never-treated male patients aged 18-65 years with a body mass index at least 25 kg/m(2) and without diabetes mellitus or secondary or stage 3 arterial hypertension were examined. WLR of retinal arterioles was assessed using scanning laser Doppler flowmetry. Urinary albumin-to-creatinine ratio (UACR) was measured from first morning spot urine. Vascular reactivity was measured by the change of aortic augmentation index (aAIx) to infusion of L-NMMA.
RESULTS: UACR was related with WLR of retinal arterioles (r = 0.352, P = 0.032). In response to L-NMMA infusion aAIx increased (from 10.7 +/- 11 to 19.7 +/- 11%, P < 0.001). The change of aAIx to L-NMMA infusion was inversely related with WLR of retinal arterioles (r = -0.462, P = 0.003) even after adjustment for changes of hemodynamic parameters to L-NMMA infusion (partial r = -0.475, P = 0.005). The relationships of UACR and the change of aAIx to L-NMMA infusion with WLR of retinal arterioles were found to be independently of other cardiovascular risk factors (ss = 0.386, P = 0.006; ss = -0.369, P = 0.004, respectively) in multiple regression analyses with separate models for both parameters.
CONCLUSION: Increased WLR of retinal arterioles may thus serve as an in-vivo marker of vascular damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625969     DOI: 10.1097/HJH.0b013e32833013fd

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus.

Authors:  Thomas Forst; Matthias M Weber; Michael Mitry; Thomas Schöndorf; Senait Forst; Mukadar Tanis; Andreas Pfützner; Georg Michelson
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  How to assess microvascular structure in humans.

Authors:  Damiano Rizzoni; Christian Aalkjaer; Carolina De Ciuceis; Enzo Porteri; Claudia Rossini; Claudia Agabiti Rosei; Annamaria Sarkar; Enrico Agabiti Rosei
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-12-01

3.  The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes.

Authors:  R Klein; M D Knudtson; B E K Klein; B Zinman; R Gardiner; S Suissa; A R Sinaiko; S M Donnelly; P Goodyer; T Strand; M Mauer
Journal:  Diabetologia       Date:  2010-05-01       Impact factor: 10.122

Review 4.  Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.

Authors:  Rita Del Pinto; Giuseppe Mulè; Maria Vadalà; Caterina Carollo; Santina Cottone; Claudia Agabiti Rosei; Carolina De Ciuceis; Damiano Rizzoni; Claudio Ferri; Maria Lorenza Muiesan
Journal:  Nutrients       Date:  2022-05-25       Impact factor: 6.706

Review 5.  Treatment of arterial remodeling in essential hypertension.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

6.  Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy.

Authors:  Thomas Forst; Matthias M Weber; Michael Mitry; Lena Müller; Senait Forst; Mukkadar Tanis; Andreas Pfützner; Georg Michelson
Journal:  J Diabetes Sci Technol       Date:  2014-02-21

7.  Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.

Authors:  Agnes Jumar; Joanna M Harazny; Christian Ott; Iris Kistner; Stefanie Friedrich; Roland E Schmieder
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-16       Impact factor: 3.738

8.  Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

Authors:  Agnes J Bosch; Joanna M Harazny; Iris Kistner; Stefanie Friedrich; Joanna Wojtkiewicz; Roland E Schmieder
Journal:  BMC Cardiovasc Disord       Date:  2017-12-21       Impact factor: 2.298

Review 9.  Retinal arterial hypertrophy: the new LVH?

Authors:  Kaivan Khavandi; Meena Arunakirinathan; Adam S Greenstein; Anthony M Heagerty
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

10.  Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study.

Authors:  Christine Berndt-Zipfel; Georg Michelson; Markus Dworak; Michael Mitry; Andrea Löffler; Andreas Pfützner; Thomas Forst
Journal:  Cardiovasc Diabetol       Date:  2013-04-08       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.